- $12.39m
- $12.68m
- CA$0.29m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 95.8 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -144.66% | ||
Financial Summary
| Year End 31st Jul | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | 0.24 | 0.25 | 0.29 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aleen Inc. is a Canada-based company. The Company is in the business of online diagnosis and health management. It creates a comprehensive tool for controlling key health indicators. The Company uses artificial intelligence to combine a monitoring system of personal medical indicators and professional doctor consultancy. Aleen Symptom Checker is the Company's AI tool for preliminary diagnosis. The Aleen Symptom Checker determines probable causes of the customer's symptoms and helps to find appropriate assistance.
Directors
- Last Annual
- July 31st, 2025
- Last Interim
- January 31st, 2026
- Incorporated
- October 7th, 2020
- Public Since
- June 6th, 2025
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 12,643,300
- Address
- 2164 Montreal Rd, Unit 5 PMB 1007, OTTAWA, K1J 1G4
- Web
- https://aleen.ca/
- Phone
- +1 6134168832
- Auditors
- MS Partners LLP
Similar to ALEN.U
Aquarius Surgical Technologies
Canadian Securities Exchange
Cannabix Technologies
Canadian Securities Exchange
Diagnostear Technologies
Canadian Securities Exchange
Imagin Medical
Canadian Securities Exchange
Izotropic
Canadian Securities Exchange
FAQ
As of Today at 19:11 UTC, shares in Aleen are trading at $0.98. This share price information is delayed by 15 minutes.
Shares in Aleen last closed at $0.98 and the price had moved by over the past 365 days. In terms of relative price strength the Aleen share price has matched the Toronto Stock Exchange 300 Composite Index by over the past year.
There is no consensus recommendation for this security.
Find out moreAleen does not currently pay a dividend.
Aleen does not currently pay a dividend.
Aleen does not currently pay a dividend.
To buy shares in Aleen you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.98, shares in Aleen had a market capitalisation of $12.39m.
Here are the trading details for Aleen:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: ALEN.U
Based on an overall assessment of its quality, value and momentum Aleen is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aleen. Over the past six months, its share price has matched the Toronto Stock Exchange 300 Composite Index by .
As of the last closing price of $0.98, shares in Aleen were trading -26.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aleen PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Aleen's directors